Innovative Diabetes Treatments Studies

Innovative Diabetes Treatments (IDT) is a specialized clinical research organization (CRO) and clinical trial site based in Munich, Germany, dedicated to the development of novel therapies for diabetes and metabolic disorders. The company provides comprehensive services for Phase 1 through Phase 4 clinical trials, leveraging its deep expertise in metabolic diseases to support pharmaceutical and biotechnology clients. IDT operates a high-end clinical research facility equipped for complex metabolic studies, including glucose clamp procedures and continuous glucose monitoring. By focusing exclusively on diabetes and related conditions, the company offers specialized recruitment and high-quality data generation for global drug development programs.